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Abstract: There may be some difficulties to differentiate Behcet’s disease (BD), recurrent aphthosis (RA), and herpetic 
aphthous ulceration, from other mimicking oral disorders. Despite of unexpected sensitivity and responsiveness, the skin 
pathergy test regarding a non-specific hypersensitivity has long been thought as one of auxiliary diagnostic benefits for 
BD. 
To determine the potential usefulness and disease specificity of the prick reaction with saliva, a skin prick test with neat 
and filter-sterilized saliva was performed on the forearm skin of 26 individuals; 10 patients with BD (8 incomplete type 
without uveitis, 1 complete type, and 1 neurological type), 5 with RA, 3 with herpetic oral aphthosis, 2 with erythema 
nodosum alone, and 6 healthy controls. We assessed the skin reaction at 48 hours after pricking, and the pricked skin 
lesions were biopsied and analyzed immunohistologically. 
Nine of 10 BD patients (90 %) exhibited an indurative erythema at the skin site pricked with self-saliva, whereas 3 of 5 
RA patients (60%) were relatively weak reaction. Pricking with filter-sterilized saliva failed to recapitulate any of positive 
skin reactions, albeit a faint erythematous dot appeared in a few BD patients, implicating the involvement of causative 
microorganism(s) in oral bacterial flora. Culture of saliva from 3 randomly chosen BD patients revealed numerous 
streptococcal colonies on Mitis-Salivarius agar. Histology of the pricked skin sites showed perivasucular inflammatory 
infiltrates, composed of CD4+ T cells and CD68+ monocyte/macrophage lineage, a feature consistent with a delayed type 
hypersensitive reaction. 
Our results suggested that skin prick test using self-saliva (a new diagnostic pathergy) can be a simple and valuable in 
vivo diagnostic approach for differentiating BD and RA from other mimicking mucocutaneous diseases. The positive skin 
prick may be triggered by resident intra-oral microflora, particularly streptococci, and may in part address the underlying 
immunopathology in BD. 
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INTRODUCTION 
  Although oral aphthous ulceration can be seen in a 
variety of mucocutaneous diseases, there may be some 
difficulties to characterize recurrent aphthosis (RA), the 
early clinical stage of Behcet’s disease (BD), and herpetic 
aphthous ulceration [1, 2]. The oral lesions in these 3 
diseases often display the similar ulcerative shape in 
appearance, but RA and herpetic aphthosis do not develop 
any of systemic symptoms. BD is a chronic multisystem 
inflammatory condition characterized by recurrent 
manifestations in mucocutaneous [e.g. oral and genital 
ulceration, erythema nodosum (EN)-like eruption, acneic 
eruption, thrombophlebitis], ocular, and vascular area, and 
relatively lesser with digestive tract and/or nervous system. 
Among these variable clinical symptoms, oral aphthous 
ulceration may represent the initial signature of BD. Besides,  
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there may be considerable variety and concomitant 
occurrence of these multiple symptoms, resulting in the 
potential difficulty for conclusive diagnosis of the disease. 
Although the etiology of BD remains unclear, the pathogenic 
axis has gradually closed to two distinct scenarios, genetic 
background and extrinsic triggering factors. The former 
genetics firmly include the higher association (~60%) with 
specific HLA haplotype, HLA-B51, without regard to their 
clinical phenotypes [3-8]. In contrast, the oral unhygienic 
condition has been suspected as one of the extrinsic factors, 
because periodontitis, decayed teeth, and chronic tonsillitis 
are frequently observed in the oral cavity of BD patients, and 
also, the exacerbation of these orodental conditions has a 
close association with the disease activity of BD [9-14]. A 
series of our investigation relevant to the intra-oral 
circumstances have suggested that more than one-third of 
BD patients tend to acquire a delayed type hypersensitivity 
(DTH) against certain streptococcal strains, as assessed by 
the skin prick test with purified streptococcal antigens [9, 10, 
15-17]. Based on the diagnostic criteria established by 
International Study Group for BD [18], this so-called 
“pathergy reaction” has been categorized as a minor 
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BD in 2003 [19, 20]. However, patients with RA may also 
show the hypersensitivity to streptococci [17], and moreover, 
the standardized streptococcal antigens for diagnostic 
purpose of BD is currently difficult to prepare. In this study, 
we aimed to determine the potential benefit and reliability of 
skin prick test using self-saliva, which mostly contains 
streptococci, for in vivo diagnosis of BD, and if any, to 
differentiate this from other mimicking mucocutaneous 
disorders. 
MATERIALS AND METHODS 
Patients 
  Patients enrolled in this study have attended to the 
Dermatology Clinic, Southern TOHOKU General Hospital. 
All 10 patients with BD were diagnosed by the criteria based 
on the International Research Group for BD and they were 
clinically classified by the Japanese criteria [6, 20]; 8 
incomplete type without uveitis (3 males and 5 females; 
mean ages, 33 year-old), a complete type with uveitis (23 
year-old male) and a neurologic type (55 year-old male). 
Comparative controls include 5 patients with RA (mean age, 
28 year-old), 3 females with herpetic oral aphthosis, 2 
females with EN alone (mean age, 50 year-old), and 6 
healthy subjects (2 males and 4 females; mean age 40 year-
old). All patients approved to receive the skin prick test for 
the diagnostic purpose after the precise informed consent. 
Except 1 BD patient (case #10, Table 1), systemic 
medication, including corticosteroids, immunosupressants, 
colchicines, and anticoagulants, was discontinued 2 week 
before the skin prick. These clinical details have been 
recognized by the local ethical committee. 
Detection of Streptococci in Saliva 
  Saliva from patients and control subjects was obtained by 
sterilized swabbing cotton, and directly cultured on Mitis-
Salivarius (MS) agar with 1% tellunite solution (Difco Lab., 
Detroit, USA). This agar allows growing up streptococcal 
species alone [21]. 
Skin Prick Test 
  Skin prick test was performed according to our previous 
study with minor modification. Part of freshly obtained self-
saliva was sterilized by a syringe filter with 0.2 m pore 
membrane (Nalgene, NY), and immediately used for the 
following prick study. The forearm skin of the patients and 
control subjects was pricked with either neat or filter-
Table 1.  Skin Prick Test with Self-Saliva in 26 Subjects 
 
Self-Saliva 
No.  Subjects  Age/Sex 
Erythema (mm)  Pustules 
FS-Saliva  Control Saline 
1  Neuro BD  55/M  11 x 15  +  nd  - 
2  Incomplete  33/F  22 x 22  -  -  - 
3   26/F  10 x 10  +  + dot  - 
4   27/M  11 x 12  +  + dot  - 
5   47/M  10 x 13  +  + dot  - 
6   36/F  5 x 10  -  nd  - 
7   46/M  10 x 10  -  -  - 
8   17/F  5 x 5  -  -  - 
9   34/F  6 x 14  -  -  - 
10  Complete  23/M  10 x 10  +  -  - 
Recurrent Aphthosis (RA) 
11  24/F    8 x 10  -  -  - 
12  28/F    8 x 4  -  -  - 
13  32/F  -   -   nd  - 
14  29/M  -   -   nd  - 
15  28/F    3 x 5  -  -  - 
Disease Controls 
16  EN  39/F  -  -  nd  - 
17   61/F  -  -  -  - 
18-20  3 Viral aphthosis  -  -  -  nd 
21-26  6 Healthy controls  -  -  -  - 
FS, filter-sterilized; BD, Behcet’s disease; EN, erythema nodosum; nd, not determined. 166     Inflammation & Allergy - Drug Targets, 2011, Vol. 10, No. 3  Togashi et al. 
sterilized self-saliva (FS self-saliva) by using a Prick-
Lancetter (OY ALGO AB Espoo/Esbo Puh90-50991, 
Sweden). The skin reaction was measured in diameter 48 
hours after the skin prick. Based on our preliminary data and 
the original pathergy reaction mostly seen in BD patients 
[18, 22], we recognized the following 3 skin reactions as 
“positive”: i) erythema and/or induration more than 10 mm 
in BD patients, ii) those more than 5 mm in other diseased 
and control subjects, iii) pustules more than 2 mm 24 hours 
in BD patients. 
Histochemistry 
  To characterize the profile of inflammatory infiltrates at 
the pricked skin sites, a skin biopsy was obtained from 
representative erythematous reaction in 3 distinct BD 
patients. The infiltrating cells were immuno-stained with 
anti-CD3, CD4, CD5, CD8, CD20, CD56 and CD68 
monoclonal antibodies (DAKO), and then with HRP-
conjugated secondary antibodies. Signals were detected by 
diaminobendizine/H2O2 substrates. The positive cells were 
counted under x200 high power magnification of a light 
microscope at least 3 distinct fields, and then expressed as 
mean cell numbers. 
RESULTS 
Strepcotoccal Species were Detectable in the Culture 
from BD Patients’ Saliva 
  Although Streptococcal species normally exist in oral 
micro-flora, certain streptococcal species, Streptococcus (S) 
sanguinis and S. mitis, were increased in saliva of BD 
patients [13, 14]. Saliva culture from 3 randomly chosen BD 
patients and healthy controls demonstrated at least 3 major 
colonies of Streptococcal strains at the 3
rd to 5
th days in MS 
agar dish (Fig. 1A). After filter-sterilization, culture from the 
same patients’ saliva did not show colony formations (Fig. 
1B). 
Patients with BD and RA Showed Positive Pathergy 
Reaction with Self-Saliva Prick 
  In 9 of 10 BD patients (90 %), skin prick with neat self-
saliva induced indurative erythema more than 10 mm (Table 
1). Five of the 9 positive patients also showed a tiny pustule 
at the pricked skin site. Interestingly, four of 7 positive 
patients turned into negative by filter-sterilized (FS)-saliva 
skin prick (Fig. 2B), and the remaining 3 patients, who had 
active aphthous ulceration, exhibited a pustular formation 
alone (Fig. 2A). A young female BD patent, who treated 
with a low dose of oral corticosteroid, showed a very mild 
erythema without pustules (case #10, Table 1). 
  In disease controls, three of 5 RA patients (60%) had a 
weak erythema with self-saliva skin prick, but they showed 
negative reaction with FS-saliva skin prick (Table 1). 
Contrary to these, patients with EN alone and herpetic oral 
aphthosis, as well as 6 healthy volunteers, did not show any 
of positive reaction with neat and FS self-saliva (Table 1). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. (1). Streptococcal colonies were grown from self-saliva of a 
representative BD patient in MS agar dish. Numerous, but three 
major colonies of Streptococci appeared at 5th day culture (A). No 
colonies were found in the area of filter-sterilized salvia (B). 
Inflammatory Infiltrates at the Pricked Skin Sites 
Revealed Th1-Dominant Immune Response 
  We next tried to characterize the profile of inflammatory 
infiltrates at the pricked skin sites in BD. Biopsy specimens 
from the pricked skin in 3 randomly chosen BD patients 
were immuno-stained with paneled antibodies. Basically, 
routine histological examination of all sections from 3 
distinct BD patients’ skin revealed interstitial edema and 
intense mononuclear cell infiltration, composed of CD4+ T 
cells (73.4%), in the upper dermis (Fig. 3A-C). Other cell 
sources included CD8+ T cells (12%) and CD68+ cells 
(38%), but neither CD20+ nor CD56+ cells were found. 
These results suggest the predominant involvement of 
antigen-presenting cells and antigen–responsive T cells at 
the self-saliva pricked skin in BD patients. 
DISCUSSION 
  There are several lines of evidence about the 
eiopathogenesis of oral disorders, such as BD, RA, and HSV 
infection, being considerable similar clinicopathology of 
aphthous ulceration. Classical skin pathergy test with a dull 
and thick needle (approximately 20 G) may often cause a 
pustule formation within 24 hours, and it has long been 
considered an important diagnostic reaction for BD [18-20]. 
The pathophysiological mechanism of this action has yet to 
be enigmatic, because the principal histology contains 
uncharacteristic inflammation; for example, variable degrees 
of vascular reaction, albeit absence of typical vasculitis, and 
non-specific perivascular inflammatory infiltrates in the 
dermis [23-29]. The sensitivity of skin pathergy in Japanese 
BD patients may be relatively lower than those in other   
 
 Skin Prick Reaction with Self-Saliva in Mucocutaneous Diseases  Inflammation & Allergy - Drug Targets, 2011, Vol. 10, No. 3     167 
(A) 
 
 
 
 
 
 
 
 
 
 
 
 
 (B) 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. (2). Skin prick reactions by freshly obtained self-saliva, filter-
sterilized self-saliva, and control saline. (A) In a 27 year-old male 
BD patient with active aphthous ulceration (case #4, Table 1), an 
intense and indurative erythema with a small pustule was 
established by a skin prick with neat self-saliva (S, left), but showed 
a tiny dot reaction by filter-sterilized self-saliva (SS, middle). A 
skin prick with control saline did not cause any of skin reactions 
(CS, right). (B) In a 26 year-old female BD patient without 
aphthous ulceration (case #3, Table 1), a very mild erythema but 
central pustules were established by a skin prick with neat (S, left) 
and filter-sterilized self-saliva (SS, middle), and even by control 
saline (CS, right). 
races, such as Mediterranean districts (30-40%) [19]. The 
sensitivity has gradually been decreasing from ~70% to 
~40% in some other countries (1970s vs 1998-2007, 
respectively) [25, 27, 30]. It is therefore unlikely that the 
diagnostic accuracy and its potential benefit of the pathergy 
reaction remain constant. Although little is known about the 
chronological decrease of the pathergy sensitivity, one may 
postulate the considerable alteration of patients’ life style, 
diet, and sanitary condition. Particularly, dietary habits have 
completely been changed in Japan, and in parallel with this, 
the prevalence of Japanese BD patients has gradually   
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Fig. (3). Histological and immunohistological characteristics of the 
pricked skin sites. Histology revealed interstitial edema and intense 
lympho-histiocytic infiltration (A, x40), but not a typical feature of 
vasculitis (B, x200), in the upper dermis. These inflammatory 
infiltrates are mainly composed of CD4+ T cells (73.4%) and to 
lesser with CD8+ T cells (12%) and CD68+ cells (38%) (C). No 
other cell sources, such as CD20+ or CD56+ cells were found. 168     Inflammation & Allergy - Drug Targets, 2011, Vol. 10, No. 3  Togashi et al. 
decreased in recent decades [31]. Apart from these 
environmental origins, a convincing evidence for the 
pathergy reaction has emerged that the povidone iodine 
sterilization preceded for skin surgery efficiently reduced the 
positive rate of pathergy reaction [28]. This finding is in 
agreement with our observation that the skin prick test was 
positive with neat saliva, but was negative with FS-saliva. 
Overall, these evidence series strongly suggest the 
involvement of intra-oral microorganism(s) in the pathergy 
reaction. 
  In our study, patients with most BD patients (9/10, 90%) 
demonstrated a positive skin prick specific for their own 
intra-oral microorganism(s). The similar trend in the skin 
prick was also found in substantial numbers of RA patients 
(3/5, 60%). Moreover, the prick reactivity can represent the 
relevant disease activity; that is, the tiny pustule appeared in 
patients with active oral ulceration, as was our recent 
investigation [22]. None of other controls (3 herpetic 
aphthous ulceration, 2 BD-unrelated EN, and 6 healthy 
subjects) had positive reactions by the self-saliva skin prick, 
indicating the highly specificity of the skin prick in BD and 
RA. Streptococcal species normally persists in the oral 
micro-flora, and more specifically, Streptococcus (S) 
sanguinis and S. mitis were increased significantly in saliva 
from BD patients [13, 14]. Combining with data 
demonstrating a hypersensitivity to oral streptococci in RA 
patients [17] and our finding that saliva culture from 
representative BD patients revealed streptococcal colonies, 
the positive skin prick reaction may be a consequence of the 
local hypersensitivity to streptococcal antigen(s). This is also 
supported by the histological similarity between oral 
aphthous lesion in BD/AU and skin pathergy reaction, 
exhibiting perivascular lympho-histiocytic infiltration in the 
dermis [15, 32, 33]. Immunohistologically, the infiltrated 
mononuclear cells were mainly composed of CD4+T cells 
and CD68+ monocyte/macrophages at the pricked skin sites, 
suggesting a DTH reaction. Moreover, the clinicopathology 
of these skin pathergy was inhibited by a low dose of 
systemic corticosteroid therapy just before the self-saliva 
skin prick, but it flared up by repeating the skin prick after 
cessation of the corticosteroid (data not shown). An 
extrapolation simply from a series of these evidences brings 
the scenario that accidental minor trauma and/or repeated 
irritation – even toothbrushing - in the oral mucous 
membrane may allow certain streptococcal species penetrate 
into the underneath oral tissue. The streptococcal antigen(s) 
can be processed to recognize properly with intra-epidermal 
immunocompetent cells, such as Langerhans cells, because 
the tip of the “Prick-Lancetter” used in this study never 
reaches to the dermis when it routinely stunk on the skin 
surface. Afterwards, the processed antigen-responsive helper 
T cells might be induced, then access to the prime-
immunized oral mucosa, and finally establish aphthous 
ulceration in BD and RA [10, 15-17]. 
  It remains unclear whether the genetic predisposition 
such as HLA-B51 association is correlated with 
streptococcal hypersensitivity in the clinicopathology of BD, 
but it is of interest that the production of IL-12 from 
peripheral blood mononuclear cells (PBMCs) stimulated by 
streptococcal antigen was rather stronger in BD patients 
without HLA-B51 than those with HLA-B51 [33, 34]. IL-12 
can potentially induce a DTH reaction and has some 
biological effects as an initial inflammatory accelerator in 
BD [35]. The serologically uncommon KTH-1 type of S. 
sanguinis is increased significantly in the oral bacterial flora 
of BD patients compared with healthy controls [12-14]. In 
addition, circulating IgG antibodies against S. sanguinis are 
highly detectable in sera from BD patients, and these 
antibodies harbor a cross immunoreactivity with synthetic 
oligopeptides of human 65k-Da heat shock protein (HSP-
65), a highly homologue of streptococcal HSP-60 [36, 37]. It 
is thus conceivable that BD patients have an acquired cross 
immunoreactivity to the similar sequences between 
streptococcal and human HSP counterpart molecules. From 
the species-specific point of view, a mouse model study has 
also demonstrated that part of clinical symptoms for BD is 
capable of recapitulating by inoculation of S. sanguinis from 
oral cavity in BD patients [38]. This suggests that the local 
immunization with S. sanguinis via oral mucous membrane 
can elicit BD-like symptoms over the certain species. BD 
and RA patients who spontaneously carry streptococci in 
their oral cavity might share the similar immune responses to 
their resident streptococci. A direct linkage between BD and 
streptococcal hypersensitivity is that Bes-1 DNA encoding 
partial  S. sanguinis genomic sequences was detectable in 
perivascularly infiltrated mononuclear cells in the 
oral/genital ulcerations and EN-like lesions of BD patients 
[39]. 
  The lesional hypersensitivity to streptococcal antigens 
may lead to variable degrees of the downstream immune 
responses, because a baseline production of pro-
inflammatory cytokines, INF-, IL-6, IL-8, and IL-12, was 
increased in PBMCs stimulated by S. sanguinis (KTH-1 
strain) antigens [33, 40, 41]. For microbacterial antigen 
recognition, ten distinct Toll-like receptor (TLR) family 
members act as innate immune receptors against bacteria, 
viruses, and fungi [42]. Although TLRs are weakly 
detectable in various human tissues, the steady-state levels of 
the expression is much higher in the oral mucosa and 
digestive tracts, both of which are highly accessible with 
exogenous antigens [43]. The expression of TLR-3, -4 and -6 
was enhanced in neutrophils and monocytes of BD patients 
when stimulated with HSP-65/60 and S. sanguinis antigens 
[44, 45]. The innate immune system may thus contribute to 
the acquisition of aberrant immune response against oral 
streptococci in the underlying immunopathogenesis of BD. 
On this basis, antibiotic therapy targeting oral streptococci 
and inducible immune tolerance using HSP-encoded 
oligopeptides can be therapeutic challenge, to inhibit the 
increased oral streptococci and the subsequent activation of 
cytokine cascades via  streptococcal antigen-driven T cells 
[10, 46, 47]. 
  In summary, the skin prick test using self-saliva (a new 
diagnostic pathergy) can be a safe and useful in vivo 
approach for differentiating BD and RA patients, particularly 
those who have active oral aphthous ulceration, from other 
mimicking oral aphthoses. The reaction is mediated by a 
hypersensitivity to Streptococci in oral resident micro-flora. 
We now warrant further evaluation for the acquired immune 
response specific for the common bacteria in some races, 
other than Japanese, and more importantly, need to address 
the mechanism detail for the establishment of such a 
primitive autoimmunity in BD and RA. Skin Prick Reaction with Self-Saliva in Mucocutaneous Diseases  Inflammation & Allergy - Drug Targets, 2011, Vol. 10, No. 3     169 
ACKNOWLEDGEMENTS 
  We deeply appreciate the valuable supports by the 
Japanese Research Committee for Behcet’s Disease 
organized by the Ministry of Health, Labour and Welfare 
(Director: Professor Yoshiaki Ishigatsubo, Department of 
Internal Medicine and Immunology, Yokohama City 
University School of Medicine, Yokohama, Japan). 
REFERENCES 
[1]  Behcet, H. Uber rezidivierende, aphthous durch ein Virus 
verursachte Geschwuere am Mund, am Auge und an den 
Genitalien. Dermatol. Wochenschri., 1937, 105, 1152-1157. 
[2]  Adamantiades, B. Sur un cas d’iritis a hypopion recidivant. Ann. 
Ocul. (Paris), 1931, 168, 271-278. 
[3]  Altenburg, A. ; Papoutsis, N. ; Orawa, H. ; Martus, P. ; Krause, I. ; 
Zouboulis, C.C. Epidemiology and clinical manifestations of 
Adamantiades-Behcet’s disease in Germany-Current pathogenic 
concepts and therapeutic possibilities. J. Dtsch. Dermatol. Ges., 
2006, 4, 49-64. 
[4]  Alpsoy, E. ; Zouboulis, C.C. ; Ehrlich, G.E. Mucocutaneous lesions 
of Behcet’s disease. Yonsei. Med, J., 2007, 48, 573-585. 
[5]  Ohno, S.; Ohguchi, M.; Hirose, S.; Matsuda, H.; Wakisaka, A.; 
Aizawa, M. Close association of HLA-Bw51 with Behcet’s 
disease. Arch. Ophthalmol., 1982, 100, 1455-1458. 
[6]  Zouboulis, C.C.; May, T. Pathogenesis of Adamantiades-Behcet’s 
disease. Med. Microbiol. Immunol., 2003, 192, 149-155. 
[7]  Karaycian, A.; Zouboulis, C.C. An update on Behcet’s disease. J. 
Eur. Acad. Dermat-Venereol., 2007, 21, 1-10. 
[8]  Krause, I.; Weinberger, A. Behcet’s disease. Curr. Opin. Rheum., 
2008, 20, 82-87. 
[9]  Kaneko, F.; Kaneda, T.; Ohnishi, O.; Kishiyama, K.; Takashima, 
K.; Fukuda, H.; Kado, Y. Infection allergy in Behcet’s disease (1). 
Jpn. J. Allergol., 1978, 27, 440-450. 
[10]  Kaneko, F.; Oyama, N.; Nishibu, A. Streptococcal infection in the 
pathogenesis of Behcet’s disese and clinical effects of minocycline 
on the disease symptoms. Yonsei. Med. J., 1997, 38, 444-454. 
[11]  Mumcu, G.; Inanc, N.; Ergan, T.; Ikiz, K.; Gunes, M.; Islek, U.; 
Yavus, S.; Sur, H.; Atalay, T.; Direskeneli, H. Oral health is 
impaired in Behcet’s disease and is associated with disease activity. 
Rheumatology (Oxford), 2004, 43, 1028-1033. 
[12]  Yokota, K.; Hayashi, S.; Araki, Y.; Isogai, E.; Kotake, S.; 
Yoshikawa, K.; Fujii, N.; Hirai, Y.; Oguma, K. Characterization of 
Streptococcus sanguis isolated from patients with Behcet’s disease. 
Microbiol. Immunol., 1995, 39, 729-732. 
[13]  Isogai, E.; Ohno, S.; Takashi, K.; Yoshikawa, K.; Turumizu, T.; 
Isogai, H.; Yokota, Y.; Hashimoto, T.; Shimizu, H.; Matsuda, H.; 
Fujii, N.; Yamaguchi, M.; Oguma, K. Close association of 
Streptococcus sanguis uncommon serotypes with Behcet’s disease. 
Bifidobacteria. Microflora., 1990, 9, 27-41. 
[14]  Isogai, E.; Ohno, S.; Kotake, S.; Isogai, H.; Tsurumizu, T.; Fujii, 
N.; Syuto, B.; Yamaguchi, M.; Matsuda, H.; Oguma, K. 
Chemiluminescence of neutrophils from patients with Behcet’s 
disease and its correlation with an increased proportion of 
uncommon selotypes of Streptococcus sanguis in the oral flora. 
Arch. Oral. Biol., 1990, 35, 43-48. 
[15]  Kaneko, F.; Takahashi, Y.; Muramatsu, Y.; Miura, Y. 
Immunological studies on aphthous ulcer and erythema nodosum-
like eruptions in Behcet’s disease. Br. J. Dermatol., 1985,  113, 
303-312. 
[16]  The Behcet’s Disease Research Committee of Japan. Skin 
hypersensitivity to streptococcal antigens and the induction of 
systemic symptoms by the antigens in Behcet’s disease A 
multicenter study. J. Rheumatol. 1989, 16, 506-511. 
[17]  Graykowski, E.A.; Baril, M.F.; Boyd, L.M.; Stanley, H.R. 
Recurrent aphthous stomatitis, Clinical therapeutic and 
histopathologic and hypersensitivity aspects. JAMA,  1966,  196, 
637-644. 
[18]  International Study Group for Behcet’s Disease. Criteria for 
diagnosis of Behcet’s disease. Lancet, 1990, 335, 1078-1080. 
[19]  Sakane, T.; Takeno, M.; Suzuki, N.; Inaba, G. Current concepts: 
Behcet’s disease. N. Eng. J. Med., 1999, 341, 1284-1291. 
[20]  Suzuki- Krokawa, M.; Suzuki, N. Behcet’s disease. Clin. Exp. 
Med., 2004, 3, 10-20. 
[21]  Emilson, C.G.; Bratthal, D. Growth of Streptococcus mutans on 
various selective media. J. Clin. Microbiol. 1976, 4, 95-98. 
[22]  Kaneko, F.; Saito, S.; Togashi, A.; Oyama, N.; Nakamura, K. Prick 
test with self-saliva as an auxiliary diagnostic measure in Behcet’s 
disease. Jpn. J. Dermatol., 2010, 120, 1901-1905. (in Japanese) 
[23]  Haim, S.; Sobel, J.D.; Friedman-Birnbaum, R.; Lichtig, C. 
Histological and direct immunofluorescence study of cutaneous 
hyperreactivity in Behcet’s disease. Br. J. Dermatol., 1976,  95, 
631-636. 
[24]  Tuzun, Y.; Yazici, H.; Pazarli, H.; Yalcin, B.; Yurdakul, S.; 
Muftuoglu, A. The usefulness of the nonspecific skin 
hyperreactivity (the pathergy test) in Behcet’s disease in Turkey. 
Acta. Dermato-Venereol. (Stockholm), 1978, 59, 77-79. 
[25]  Davies, P.G.; Fordham, J.N.; Kirwan, J.R.; Barnes, C.G.; Dinning, 
W.J. The pathergy test and Behcet’s syndrome in Britain. Ann. 
Rheum. Dis., 1984; 43, 70-73. 
[26]  Jorizzo, J.L.; Solomon, A.R. Behcet’s disease. Immunopathologic 
and histologic assessment of pathergy lesions is useful in diagnosis 
and follow-up. Arch. Pathol. Lab. Med., 1985, 109, 747-741. 
[27]  Friedman-Birnbaun, R.; Bergman, R.; Aizen, E. Sensitivity and 
specificity of pathergy test results in Israeli patients with Behcet’s 
disease. Cutis, 1990, 45, 261-264. 
[28]  Fresko, I.; Yazici, H.; Bayramicli, M.; Yurdakul, S.; Mat, C. Effect 
of surgical cleaning of the skin on the pathergy phenomenon in 
Behcet’s syndrome. Ann. Rheum. Dis., 1933, 52, 619-620. 
[29]  Inaloz, H.S.; Everekliosgluu, C.; Unal, B.; Kirtak, N.; Eralp, A.; 
Inaloz, S.S. The significans of immunohistochemistry in the skin 
pathergy reaction of patients with Behcet’s syndrome. J. Eur. Acad. 
Dermatol. Venereol., 2004, 18, 56-61. 
[30]  Davachi, F.; Chans-Davachi, C.; Shahram, F.; Nadji, A.; Shams, 
H.; Ghodsi, Z.; Akhlaghi, M.; Naderi, N.; Sadeghi-Abdolahi, B. 
Pathergy test in Behcet’s disease in incidence over the time. 
APKAR. J. Rheumatol., 2007, 10, 333-335. 
[31]  The Report of the Research Committee of Behcet’s Disease. 
Japanese Ministry of Health, Labour and Welfare. Ishigatsubo, Y., 
2010 (in Japanese). 
[32]  Jorrizzo, J.L.; Abernothy, J.L.; White, W.L.; Mongelsdorf, H.C.; 
Zouboulis, C.C.; Sarica, R.; Gaffney, K.; Mat, C.; Yazici, H.; Al 
Lalaan, A.; Assad-Kahalil, S.H.; Kaneko, F.; Jorizzo, E.A.F. 
Mucocutaneous criteria for the diagnosis of Behcet’s disease: an 
analysis of clinicopathologic data from multiple international 
centers. J. Am. Acard. Dermatol., 1995, 32, 968-976. 
[33]  Lew, W.; Chang, J.Y.; Jung, T.Y.; Bang, D. Increased expression 
of interleukin-23 p19 mRNA in erythema nodosum-like lesion of 
Behcet’s disease. Br. J. Dermatol., 2008, 158, 505-511. 
[34]  Yanagihori, H.; Oyama, N.; Nakamura, K.; Mizuki, N.; Oguma, K.; 
Kaneko, F. Role of IL-12B promoter polymorphisum in 
Adamantiades-Behcet’s disease susceptibility: An involvement of 
Th1 immmunoreactivity against Streptococcus sanguinis antigen. J. 
Invest. Dermatol., 2006, 126, 1534-1540. 
[35]  Kaneko, F.; Togashi, A.; Saito, S.; Sakuma, H.; Oyama, N.; 
Nakamura, K.; Yokota, K.; Oguma, K. The role of the IL-12 
cytokine family in oral disease: Behcet’s disease (Adamantiades-
Behcet’s disease). Clin. Dev. Immunol., 2011, 2011, 681956. 
[36]  Isogai, E.; Isogai, H.; Kotake, S.; Ohno, S.; Ishihara, M.; Aeki, K.; 
Tojo, M.; Kaneko, F.; Yokota, K.; Oguma, K. Antibody cross 
reactivity from sera of patients with Behcet’s disease with synthetic 
peptides that have homologies with protein from Streptococcus 
sanguis. J. Appl. Res., 2002, 2, 1-7. 
[37]  Yoshikawa, K.; Kotake, S.; Kubota, T.; Kimura, K.; Isogai, E.; 
Fujii, N. Cloning and sequencing of BES-1 gene encoding the 
immunogenic antigen of Streptococcus sanguis KTH-1 isolated 
from patients with Behcet’s disease. Zentbl. Bakteriol., 1998, 287, 
449-460. 
[38]  Isogai, E.; Isogai, H.; Kotake, S.; Ohno, S.; Ikimura, K.; Oguma, K. 
Role of Streptococcus sanguis and traumatic factors in Behcet’s 
disease. J. Appl. Res., 2003, 3, 64-75. 
[39]  Tojo, M.; Yanagihori, H.; Zheng, X.; Oyama, N.; Isogai, E.; 
Kimura, K.; Nakamura, K.; Kaneko, F. Bes-1 DNA fragment 
encoding Streptococcal antigen in skin lesions from patients with 
Behcet’s disease. J. Appl. Res., 2003, 3, 232-238. 
[40]  Kaneko, F.; Takahashi, Y.; Muramatsu, R.; Minagawa, T. Natural 
killer cell numbers and function in peripheral lymphoid cells in 
Behcet’s disease. Br. J. Dermatol., 1985, 113, 313-318. 170     Inflammation & Allergy - Drug Targets, 2011, Vol. 10, No. 3  Togashi et al. 
[41]  Hirohata, S.; Oka, H.; Mizushima, Y. Streptococcal antigens 
stimulate production of IL-6 and interferon- by cells from patients 
with Behcet’s disease. Cell. Immunol., 1992, 140, 410-419. 
[42]  Zarember, K.A.; Godowski, P.J. Tissue expression of human Toll-
like receptors and differential regulation of Toll-like receptor 
mRNAs in leukocytes in response to microbes, their products, and 
cytokines. J. Immunol., 2002, 168, 554-561. 
[43]  Hornung, V.; Rothenfusser, S.; Britsch, S.; Krug, A.; Jahrsdörfer, 
B.; Giese, T.; Endres, S.; Hartmann, G. Quantitative expression of 
Toll-like receptor 1-10 mRNA in cellular subsets of human 
peripheral blood mononuclear cells and sensitivity to CpG 
oligodeoxynucleotides. J. Immunol., 2002, 168, 4531-4537. 
[44]  Durranni, O.; Wallace, G.R.; Hamburger, J.; Hamburger, J. Toll-
like receptors (TLRs) expression in oral ulcer biopsies from 
Behcet’s disease (BD) patients, a role for the innate immune syste 
in BD. Clin. Exp. Rheumatol., 2004, 22(Suppl. 34), S1-93. 
[45]  Yavus, S.; Elbir, Y.; Tulunay, A.; Ekisioglu-Demirap, E.; 
Direskeneli, H. Differential expression of toll-like receptor 6 on 
granulocytes and monocytes implicates the role of microorganisms 
in Behcet’s disease etiopathogenesis. Rheumatol. Int.,  2008,  28, 
401-406. 
[46]  Mumcu, G.; Inac, N.; Yavuz, S.; Direskeneli, H. The role of 
infectious agents in the pathogenesis, clinical manifestations and 
treatment strategies in Behcet’s disease. Clin. Exp. Rheumatol., 
2007, 25, S27-33. 
[47]  Stanford, M.; Whittal, T.; Bergemeier, L.A.; Lindhald, M.; Lundin, 
S.; Shinneck, T.; Mizushima, Y.; Halmgren, J.; Lehner, T. Oral 
toleration with peptides 336-351 linked to cholera toxin B subunit 
in preventing relapses of uveitis in Behcet’s disease. Clin. Exp. 
Immunol., 2004, 137, 201-208. 
 
 
Received: October 4, 2010  Revised: November 22, 2010  Accepted: December 3, 2010 